Conecte-se

Bibliografias temáticas / Immunopsychiatrie / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Immunopsychiatrie.

Artigos de revistas sobre o tema "Immunopsychiatrie"

Autor: Grafiati

Publicado: 9 de novembro de 2024

Última modificação: 27 de julho de 2025

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 47 melhores artigos de revistas para estudos sobre o assunto "Immunopsychiatrie".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Pandarakalam, James Paul. "Quantum, Brain, and Immunity Triangle in Mental Health and Neurosciences." NeuroQuantology 19, no. 8 (2021): 131–40. http://dx.doi.org/10.14704/nq.2021.19.8.nq21124.

Texto completo da fonte

Resumo:

Immunopsychiatry is a fledgling research field with great potential in the etiological research of psychotic disorders and can turn out to be helpful in finding novel treatment strategies and repurposing existing therapeutic agents. The clinical applications of Neuroquantology complement some of the etiological views of psychotic disorders that are evolving in immunopsychiatry. The pathogenesis of psychotic process may involve an underlying immune disturbance leading to neuro-quantological disorders. The cytokine storm that occurs due to COVID-19 and the resulting neurotoxic effects illustrate

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Khandaker, G. M., R. Dantzer, and P. B. Jones. "Immunopsychiatry: important facts." Psychological Medicine 47, no. 13 (2017): 2229–37. http://dx.doi.org/10.1017/s0033291717000745.

Texto completo da fonte

Resumo:

Accumulating evidence indicate a role for the immune system particularly inflammation and autoimmunity in the aetiology of major psychiatric disorders such as depression and schizophrenia. In this paper, we discuss some of the key advances in immunopsychiatry in order to highlight to psychiatrists and other health professionals how an increased understanding of this field might enhance our knowledge of illness mechanism and approaches to treatment. We present a brief overview of clinical research that link inflammation and autoimmunity with depression and psychosis, including potential role of

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Pariante, Carmine M. "Psychoneuroimmunology or immunopsychiatry?" Lancet Psychiatry 2, no. 3 (2015): 197–99. http://dx.doi.org/10.1016/s2215-0366(15)00042-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Konsman, Jan. "Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation." Pharmaceuticals 12, no. 1 (2019): 29. http://dx.doi.org/10.3390/ph12010029.

Texto completo da fonte

Resumo:

The possibility that inflammation plays a causal role in major depression is an important claim in the emerging field of immunopsychiatry and has generated hope for new treatments. The aims of the present review are first to provide some historical background and to consider the evidence in favor of the claim that inflammation is causally involved in major depression. The second part discusses some of the possibilities allowed for by the use of broad ‘umbrella’ concepts, such as inflammation and stress, in terms of proposing new working hypotheses and potential mechanisms. The third part revie

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Benedetti, Francesco. "Immunopsychiatry after COVID-19." Journal of Affective Disorders Reports 12 (April 2023): 100521. http://dx.doi.org/10.1016/j.jadr.2023.100521.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

de Abreu, Murilo S., Ana C. V. V. Giacomini, Rodrigo Zanandrea, et al. "Psychoneuroimmunology and immunopsychiatry of zebrafish." Psychoneuroendocrinology 92 (June 2018): 1–12. http://dx.doi.org/10.1016/j.psyneuen.2018.03.014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Halaris, Angelos. "WPA section's status and actual developments in psychiatric immunology/immunopsychiatry perspectives on a new era: Immunopsychiatry." Journal of Affective Disorders Reports 14 (December 2023): 100665. http://dx.doi.org/10.1016/j.jadr.2023.100665.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

The Lancet Psychiatry. "Mind and antibody: the return of immunopsychiatry." Lancet Psychiatry 2, no. 3 (2015): 191. http://dx.doi.org/10.1016/s2215-0366(15)00057-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Marques, Frederico Moraes Cardoso, Antônio Egídio Nardi, Antonio L. Teixeira, and Leonardo Caixeta. "Immunopsychiatry: an update on autoimmune encephalitis for neuropsychiatrists." Expert Review of Neurotherapeutics 22, no. 2 (2022): 155–67. http://dx.doi.org/10.1080/14737175.2022.2038136.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Leboyer, Marion, José Oliveira, Ryad Tamouza, and Laurent Groc. "Is it time for immunopsychiatry in psychotic disorders?" Psychopharmacology 233, no. 9 (2016): 1651–60. http://dx.doi.org/10.1007/s00213-016-4266-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Al-Diwani, Adam, Toby Pillinger, and Belinda Lennox. "Immunopsychiatry in 2021: premise to promise, and back again." Lancet Psychiatry 9, no. 1 (2022): 11–12. http://dx.doi.org/10.1016/s2215-0366(21)00466-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

De Picker, L. J. "The future of immunopsychiatry: Three milestones to clinical innovation." Brain, Behavior, & Immunity - Health 16 (October 2021): 100314. http://dx.doi.org/10.1016/j.bbih.2021.100314.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Horn, Sarah R., Sara J. Weston, and Philip A. Fisher. "Identifying causal role of COVID-19 in immunopsychiatry models." Brain, Behavior, and Immunity 88 (August 2020): 6–8. http://dx.doi.org/10.1016/j.bbi.2020.05.066.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Miller, Andrew H., Michael Berk, Gilles Bloch, et al. "Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry." Brain, Behavior, and Immunity 125 (March 2025): 319–29. https://doi.org/10.1016/j.bbi.2025.01.002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Benedetti, Francesco, and Benedetta Vai. "New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging." European Neuropsychopharmacology 69 (April 2023): 56–57. http://dx.doi.org/10.1016/j.euroneuro.2023.01.003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Güngör, Ekin S., and Onur Durmaz. "A case of psoriasis following clozapine treatment: Considerations for immunopsychiatry." Indian Journal of Psychiatry 66, no. 4 (2024): 407–8. http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_53_24.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Pariante, Carmine M. "The year of immunopsychiatry: A special issue that foresaw the future." Psychoneuroendocrinology 103 (May 2019): 49–51. http://dx.doi.org/10.1016/j.psyneuen.2019.01.002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Hansen, Niels. "NMDAR autoantibodies in psychiatric disease - An immunopsychiatric continuum and potential predisposition for disease pathogenesis." Journal of Translational Autoimmunity 5 (2022): 100165. http://dx.doi.org/10.1016/j.jtauto.2022.100165.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Penninx, Brenda W. J. H. "Psychiatric symptoms and cognitive impairment in “Long COVID ”: the relevance of immunopsychiatry." World Psychiatry 20, no. 3 (2021): 357–58. http://dx.doi.org/10.1002/wps.20913.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Moriarity, Daniel P. "Building a replicable and clinically-impactful immunopsychiatry: Methods, phenotyping, and theory integration." Brain, Behavior, & Immunity - Health 16 (October 2021): 100288. http://dx.doi.org/10.1016/j.bbih.2021.100288.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Lawson, W., R. Strawbridge, W. Barber, et al. "Inflammation and depression in clinical practice: initial data from a specialised immunopsychiatry clinic." Neuroscience Applied 3 (2024): 104968. https://doi.org/10.1016/j.nsa.2024.104968.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

De Picker, Livia. "Trauma-informed immunopsychiatry: the moderating role of early life adversity on inflammatory responses." Psychoneuroendocrinology 160 (February 2024): 106727. http://dx.doi.org/10.1016/j.psyneuen.2023.106727.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Sălcudean, Andreea, Cristina-Raluca Bodo, Ramona-Amina Popovici, et al. "Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review." Biomolecules 15, no. 4 (2025): 502. https://doi.org/10.3390/biom15040502.

Texto completo da fonte

Resumo:

Depression is a multifactorial psychiatric condition with complex pathophysiology, increasingly linked to neuroinflammatory processes. The present review explores the role of neuroinflammation in depression, focusing on glial cell activation, cytokine signaling, blood–brain barrier dysfunction, and disruptions in neurotransmitter systems. The article highlights how inflammatory mediators influence brain regions implicated in mood regulation, such as the hippocampus, amygdala, and prefrontal cortex. The review further discusses the involvement of the hypothalamic–pituitary–adrenal (HPA) axis, o

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Dantzer, Robert. "Can Immunopsychiatry Help in Understanding the Basis of Sex Differences in Major Depressive Disorder?" Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4, no. 7 (2019): 606–7. http://dx.doi.org/10.1016/j.bpsc.2019.04.011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Hansen, Niels, Kristin Rentzsch, Sina Hirschel, Claudia Bartels, Jens Wiltfang, and Berend Malchow. "Long-Term Course of Neural Autoantibody-Associated Psychiatric Disorders: Retrospective Data from a Specifically Immunopsychiatric Outpatient Clinic." Antibodies 12, no. 2 (2023): 34. http://dx.doi.org/10.3390/antib12020034.

Texto completo da fonte

Resumo:

Background: Autoantibody-associated psychiatric disorders are a new terrain that is currently underrepresented considering immunopsychiatry’s potential importance for therapeutic aspects. The aim of our research was thus to present initial pilot data on the long-term clinical course of our patients in an outpatient clinic specializing in autoantibody-associated psychiatric disorders. Methods: Thirty-seven patients were examined clinically in our outpatient clinic at regular intervals over a 1.5-year period. We collected clinical data on their demographics, psychopathology, and cognition, and m

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Pariante, Carmine M. "Did Spider-Man Work in the NESDA Cohort? In Immunopsychiatry, With Great Power Comes Great Responsibility." Biological Psychiatry 85, no. 10 (2019): 787–88. http://dx.doi.org/10.1016/j.biopsych.2019.03.980.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Hao, Fengyi, Wanqiu Tan, Li Jiang, et al. "Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry." Brain, Behavior, and Immunity 87 (July 2020): 100–106. http://dx.doi.org/10.1016/j.bbi.2020.04.069.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Schalbetter, Sina-Maria, Kara Dawson, Flavia Müller, et al. "T179. WHEN TOO LITTLE IS TOO MUCH: TEMPORARY PREFRONTAL MICROGLIA DEFICIENCY DURING ADOLESCENCE IMPAIRS ADULT BRAIN FUNCTIONS." Schizophrenia Bulletin 46, Supplement_1 (2020): S299—S300. http://dx.doi.org/10.1093/schbul/sbaa029.739.

Texto completo da fonte

Resumo:

Abstract Background Aberrant activity of microglia, the primary innate immune cells of the brain parenchyma, may play a role in the etiology and pathophysiology of schizophrenia and related disorders. While current immunopsychiatric research indicates that microglial hyperactivity may contribute to psychotic illness in some cases, the diametrical opposite (i.e. microglial hypoactivity) may be pathologically and therapeutically relevant for others. The latter hypothesis, however, remains largely unexplored and thus warrants investigation. Methods We aimed at developing a model system in mice, i

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Nicholson, Tim. "Sensorimotor features in Autism." Journal of Neurology, Neurosurgery & Psychiatry 94, no. 12 (2023): e2.38. http://dx.doi.org/10.1136/jnnp-2023-bnpa.7.

Texto completo da fonte

Resumo:

Tim Nicholson is a Reader in Neuropsychiatry at the Institute of Psychiatry Psychology & Neuroscience (IoPPN), King’s College London where he leads the Neuropsychiatry Research and Education Group. He is an Honorary Consultant Neuropsychiatrist at the South London and Maudsley NHS Foundation Trust and King’s College Hospital NHS Foundation Trust where he currently runs a Long COVID clinic focusing on neuropsychiatric complications.His clinical work and research covers the full spectrum of neuropsychiatry, but with a particular interest in Functional Neurological Disorder (FND) and immunops

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Poletti, *Sara, Raffaella Zanardi, Alessandra Mandelli, et al. "EFFICACY OF LOW-DOSE INTERLEUKIN 2 AS ADD-ON IN THE TREATMENT OF UNIPOLAR AND BIPOLAR DEPRESSION." International Journal of Neuropsychopharmacology 28, Supplement_1 (2025): i49. https://doi.org/10.1093/ijnp/pyae059.086.

Texto completo da fonte

Resumo:

Abstract Background Immune-inflammatory mechanisms are promising targets for antidepressant pharmacology [1-3]. Based on reported immune cell abnormalities, we defined an antidepressant potentiation treatment with add-on low-dose interleukin 2 (IL-2), a T-cell growth factor of proven anti-inflammatory efficacy in autoimmune conditions, increasing thymic production of naï ve CD4+ T cells [4-6], and possibly correcting the partial T cell defect observed in mood disorders [7, 8]. Aims & Objectives We performed a single-center, randomised, double-blind, placebo-controlled phase II trial in dep

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

"This Issue: Immunopsychiatry." Psychiatric Annals 42, no. 9 (2012): 314–15. http://dx.doi.org/10.3928/00485713-20120906-03.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Moriarity, Daniel P., and George M. Slavich. "Toward a dynamic immunopsychiatry." Brain, Behavior, and Immunity, February 2024. http://dx.doi.org/10.1016/j.bbi.2024.02.011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Hansen, Niels. "Immunopsychiatry – Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases." Frontiers in Immunology 13 (May 23, 2022). http://dx.doi.org/10.3389/fimmu.2022.867229.

Texto completo da fonte

Resumo:

Background Anti-neural autoantibody-associated psychiatric disease is a novel field in immunopsychiatry that has been attracting attention thanks to its potentially positive therapeutic outcome and distinct prognosis compared with non-organic psychiatric disease. This review aims to describe recent novel technological developments for improving diagnostics in the field of autoantibody-related psychiatric disease.MethodsWe screened for relevant articles in PubMed for this narrative article. We focused on research methods such as neuroimaging, immune cells and inflammation markers, and molecular

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Cunningham, Janet L., Gunnel Nordmark, David Fällmar, et al. "Experiences in Implementing Immunopsychiatry in Real Life." Journal of Affective Disorders Reports, May 2023, 100597. http://dx.doi.org/10.1016/j.jadr.2023.100597.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Pandarakalam, James Paul. ""Certain Immunity Challenges of Covid-19; Neurotoxic Effects and Immunopsychiatry"." Gerontology & Geriatrics Studies 6, no. 5 (2021). http://dx.doi.org/10.31031/ggs.2021.06.000650.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Pandarakalam, James Paul. "Certain Immunity Challenges of Covid-19; Neurotoxic Effects and Immunopsychiatry." Gerontology & Geriatrics Studies 7, no. 1 (2021). http://dx.doi.org/10.31031/ggs.2021.07.000651.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Moriarity, Daniel P., and George M. Slavich. "The future is dynamic: A call for intensive longitudinal data in immunopsychiatry." Brain, Behavior, and Immunity, June 2023. http://dx.doi.org/10.1016/j.bbi.2023.06.002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

De Picker, Livia J., and Benno C. M. Haarman. "Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker." European Journal of Nuclear Medicine and Molecular Imaging, March 18, 2021. http://dx.doi.org/10.1007/s00259-021-05308-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

von Mücke-Heim, Iven-Alex, and Jan M. Deussing. "The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside." Neuropharmacology, December 2022, 109366. http://dx.doi.org/10.1016/j.neuropharm.2022.109366.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Pandarakalam, James, and James Pandarakalam. "Analysis of an Epidemiological Anomaly of COVID-19: Transcultural and Immunological Psychiatry." Clinical Microbiology and Research, February 10, 2021, 1–6. http://dx.doi.org/10.31487/j.cmr.2021.01.01.

Texto completo da fonte

Resumo:

Evidence exists for an epidemiological trend of transmission concentrations of COVID-19 within migrant communities from tropical weather conditions. Minority groups are over-represented in hospitalisations and deaths from the virus, and it appears that the observed anomaly may be due to multifactorial causes. Underactive immune responses in cooler temperatures and diminished synthesis of vitamin D, both of which are associated with genetic factors among ethnic minority groups, could help to explain the higher incidence of COVID-19 among ethnic minority communities. Neither factor is specific t

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Moriarity, Daniel P., Summer Mengelkoch, and George M. Slavich. "Incorporating causal inference perspectives into psychoneuroimmunology: A simulation study highlighting concerns about controlling for adiposity in immunopsychiatry." Brain, Behavior, and Immunity, June 2023. http://dx.doi.org/10.1016/j.bbi.2023.06.022.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Jones, Brett D. M., Zafiris J. Daskalakis, Andre F. Carvalho, et al. "Inflammation as a treatment target in mood disorders: review." BJPsych Open 6, no. 4 (2020). http://dx.doi.org/10.1192/bjo.2020.43.

Texto completo da fonte

Resumo:

Background Mood disorders, i.e. major depressive disorder (MDD) and bipolar disorders, are leading sources of disability worldwide. Currently available treatments do not yield remission in approximately a third of patients with a mood disorder. This is in part because these treatments do not target a specific core pathology underlying these heterogeneous disorders. In recent years, abnormal inflammatory processes have been identified as putative pathophysiological mechanisms and treatment targets in mood disorders, particularly among individuals with treatment-resistant conditions. Aims In thi

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Teixeira, Antonio L., Izabela G. Barbosa, Moises E. Bauer, and Aline S. de Miranda. "Immunopsychiatry of late life depression: role of aging-related immune/inflammatory processes in the development and progression of depression." Acta Neuropsychiatrica, June 13, 2025, 1–43. https://doi.org/10.1017/neu.2025.10019.

Texto completo da fonte

Resumo:

Abstract Background: Late-life depression (LLD) arises from a complex interplay among biological, psychological, and social factors. Biologically, three main hypotheses have been proposed to explain the distinct clinical features of LLD. The vascular hypothesis supports vascular-related white matter changes in the development of LLD, while the neurodegenerative hypothesis suggests that LLD might be a prodrome of neurodegenerative diseases. The inflammatory hypothesis, which is the main focus of this review, posits that heightened inflammation underlies LLD directly or indirectly through neurod

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Melamed, Isaac, Shamma Rahman, Heather Pein, et al. "IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measures." Frontiers in Immunology 15 (October 3, 2024). http://dx.doi.org/10.3389/fimmu.2024.1383973.

Texto completo da fonte

Resumo:

IntroductionPediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterized by abrupt onset of obsessive-compulsive disorder or eating restriction along with the abrupt onset of other co-occurring symptoms (tics, behavioral and cognitive regression, etc.). PANS is thought to be a post-infectious immunopsychiatric disorder, although as with most post-infectious disorders, it is challenging to establish a causal relationship with proposed infectious triggers. Intravenous immunoglobulin (IVIG) can modulate inflammation and support the elimination of infection and has been used for treatme

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Borsini, Alessandra. "Alessandra Borsini: What neuroinflammation has to do with depression and how nutrition can play a beneficial role." Brain Medicine, April 24, 2024, 1–3. http://dx.doi.org/10.61373/bm024k.0037.

Texto completo da fonte

Resumo:

Alessandra Borsini is a Lecturer in Psychoneuroimmunology at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London. Her research interest focuses on the role of inflammation and stress on brain neurogenic alterations, particularly in the context of neuropsychiatric and neurodegenerative disorders, and on the ability of psychotropic, anti-inflammatory, and nutrition-based treatments to prevent such alterations. She has been a member of the Medical Research Council (MRC) Immunopsychiatry Consortium, the AMBROSIAC ERA-NET/MRC Consortium, and the European College

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Mac Giollabhui, N., S. Foster, C. A. Lowry, D. Mischoulon, C. Raison, and M. Nyer. "Interleukin-6 receptor antagonists in immunopsychiatry: can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?" Brain, Behavior, and Immunity, April 2022. http://dx.doi.org/10.1016/j.bbi.2022.04.009.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Da Cruz Morais, Lidiane, and Ana Karolina Marques Moriel Tavares. "Letter to editor about the article “Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry” (Hao et al., 2020)." Brain, Behavior, and Immunity, December 2020. http://dx.doi.org/10.1016/j.bbi.2020.12.015.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!